USA: Incidence Cases of Castrate-Resistant Prostate Cancer 2021-2032
[vc_row][vc_column][vc_custom_heading text="USA: Incidence Cases of Castrate-Resistant Prostate Cancer 2021-2032" font_container="tag:h2|text_align:center" use_theme_fonts="yes"][/vc_column][/vc_row][ ...
Pharming Group’s Joenja® receives FDA approval for the treatment of rare APDS condition in Adults and Pediatric patients
Pharming Group N.V. has received FDA approval for Joenja® (leniolisib) to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in patients aged 12 and above. Joenja® is a selective ...